Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

earnings

A collection of 146 Posts

Kexing Biopharm Secures Marketing Approvals for Sorafenib Generic in Egypt and Peru post image

Kexing Biopharm Secures Marketing Approvals for Sorafenib Generic in Egypt and Peru

Novo Nordisk Announces Global Workforce Reduction and Organizational Transformation, Impacting Irish Operations post image

Novo Nordisk Announces Global Workforce Reduction and Organizational Transformation, Impacting Irish Operations

GSK Appoints Luke Miels as CEO Amidst Looming US Tariffs and Strategic Growth Initiatives post image

GSK Appoints Luke Miels as CEO Amidst Looming US Tariffs and Strategic Growth Initiatives

API Manufacturer Virupaksha Organics Files for Rs 740-Crore IPO with SEBI post image

API Manufacturer Virupaksha Organics Files for Rs 740-Crore IPO with SEBI

Aptus Pharma Debuts on BSE SME Platform Following Highly Subscribed IPO post image

Aptus Pharma Debuts on BSE SME Platform Following Highly Subscribed IPO

US 100% Pharma Tariffs: Singapore's Industry Navigates Uncertainty Amid Global Supply Chain Concerns post image

US 100% Pharma Tariffs: Singapore's Industry Navigates Uncertainty Amid Global Supply Chain Concerns

PhRMA Initiatives Propel Direct-to-Patient Model, Novartis Leads with Cosentyx Platform post image

PhRMA Initiatives Propel Direct-to-Patient Model, Novartis Leads with Cosentyx Platform

AstraZeneca's US Listing Plans Spark Concerns for UK Life Sciences Investment post image

AstraZeneca's US Listing Plans Spark Concerns for UK Life Sciences Investment

PhRMA Unveils Direct-to-Patient Drug Platform to Address Pricing and Access post image

PhRMA Unveils Direct-to-Patient Drug Platform to Address Pricing and Access

Trump Administration's Drug Pricing Initiative: Industry Responses and Policy Outlook post image

Trump Administration's Drug Pricing Initiative: Industry Responses and Policy Outlook

US Tariffs on Patented Drugs: Limited Earnings Impact for Indian Pharma, Sun Pharma Faces Supply Chain Decisions post image

US Tariffs on Patented Drugs: Limited Earnings Impact for Indian Pharma, Sun Pharma Faces Supply Chain Decisions

USFDA Reports Multiple Drug Recalls by Major Indian Pharma Firms Over Quality Concerns post image

USFDA Reports Multiple Drug Recalls by Major Indian Pharma Firms Over Quality Concerns